Free Trial
→ Crypto Gets Official Government Backing—Here's the Winner (From Crypto 101 Media) (Ad)tc pixel Free IPHYF Stock Alerts

Innate Pharma (IPHYF) SEC Filings & 10K Form

Innate Pharma logo
$2.00 +0.38 (+23.46%)
As of 09/12/2025 01:55 PM Eastern
Compare

Recent Innate Pharma SEC Filings

Export to Excel
DateFilerForm TypeView
09/10/2025
5:06 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/02/2025
7:52 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/04/2025
5:49 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2025
5:24 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/07/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2025
5:05 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2025
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2025
7:31 AM		Innate Pharma (Subject)
Innate Pharma SA (Subject)
NOVO NORDISK A S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2025
5:11 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2025
5:17 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/19/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2025
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2025
5:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2025
10:31 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2025
8:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/29/2025
5:48 PM		Innate Pharma (Subject)
Innate Pharma SA (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SCHEDULE 13G/A
04/29/2025
2:02 PM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/28/2025
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2025
7:28 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
5:05 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
5:07 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2025
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
6:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2025
6:07 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2025
6:23 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2025
6:24 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2025
5:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
5:16 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
6:57 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
7:16 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/10/2025
5:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
6:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/09/2024
5:04 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/06/2024
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2024
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
5:02 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/19/2024
5:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2024
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2024
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
6:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
5:11 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
5:15 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (OTCMKTS:IPHYF) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners
Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...
Paradigm Press | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel
College grad makes $64,000 a month
A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...
Stansberry Research | Sponsoredtc pixel
Warren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the Nasdaq
New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...
Altimetry | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel
Apple’s falling behind
Apple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...
Porter & Company | Sponsoredtc pixel
6-Figure Target for BTC by 2025
The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...
Crypto 101 Media | Sponsoredtc pixel